HHS Secretary Tommy G. Thompson today announced the award of two contracts totaling up to $20 million in first-year funding to develop safer smallpox vaccines. The three-year contracts were awarded to Bavarian Nordic A/S of Copenhagen, Denmark, and Acambis Inc. of Cambridge, Mass. The National Institute of Allergy and Infectious Diseases (NIAID) will administer the contracts.
A new study suggests smallpox vaccine immunity may last far longer than expected. Scientists had believed that the vaccine generally only conferred protection from the deadly virus for about a decade. But a study released this week found evidence that people may be covered for 35 years or more, meaning many Americans could retain some level of immunity. The study looked at blood samples from laboratory workers who had been immunized in the last five years and those who had been vaccinated up to 35 years earlier.